Erlotinib 13C6 Hydrochloride
| Product Name | Erlotinib 13C6 Hydrochloride |
|---|---|
| Alternate Names | Erlotinib Stable Isotopes, Stable Isotopes of Erlotinib |
| CAT No. | CS-O-00724 |
| CAS No. | 1210610-07-3 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 435.85 g/mol |
| Mol. For. | C₁₆¹³C₆H₂₄ClN₃O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Erlotinib |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | C#C[13C]1=[13CH][13CH]=[13CH][13C](NC2=NC=NC3=C2C=C(OCCOC)C(OCCOC)=C3)=[13CH]1.Cl |
| Canonical Smiles | COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl |
| InchIKey | GTTBEUCJPZQMDZ-WQQMTWEQSA-N |
| Inchl | InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H/i5+1,6+1,7+1,12+1,16+1,17+1; |
| IUPAC | N-(5-ethynyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Erlotinib 13C6 hydrochloride is a chemotherapeutic drug that is used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the activity of the epidermal growth factor receptor (EGFR), which is a protein that is overexpressed in some cancer cells and promotes their growth and survival. By blocking the activity of EGFR, erlotinib 13C6 hydrochloride can slow down or stop the growth of cancer cells, which can help to shrink tumors and improve the patient’s condition.
Erlotinib 13C6 hydrochloride is an isotopically labeled version of erlotinib hydrochloride, which means that it contains six carbon atoms that have been replaced with the stable isotope carbon-13. This labeling is useful for researchers who want to study the metabolism and pharmacokinetics of erlotinib in the body, because it allows them to track the drug using mass spectrometry and other analytical techniques.
The chemical formula of erlotinib 13C6 hydrochloride is C22H16ClN3O4. It is a white to pale yellow crystalline powder that is soluble in water, methanol, and ethanol. The drug is typically administered orally in tablet form, and the recommended dosage varies depending on the patient’s condition and other factors.
Overall, erlotinib 13C6 hydrochloride is a valuable tool for cancer researchers and clinicians who are working to develop better treatments for lung and pancreatic cancer. By inhibiting EGFR activity, this drug has the potential to improve patient outcomes and extend survival in these difficult-to-treat cancers.
Get an Instant Quote
Related Compounds
Erlotinib D8 | Erlotinib D6 Hydrochloride | Erlotinib D6 | O-Desmethylerlotinib-d4 | O-Desmethylerlotinib hydrochloride 13C6 |